✦ LIBER ✦

Transplantation of autologous peripheral blood stem cells improved diabetic peripheral neuropathy

✍ Scribed by Sun, Hong Bo; Xia, Sheng Mei; Li, Yun; Zhao, Yan; Li, Wei Wei; Li, Hong; Wang, Jing; Wang, Zhou; Ding, Xin Min; Wang, Mei

Book ID: 109846720
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 239 KB
Volume: 18
Category: Article
ISSN: 0007-0610
DOI: 10.1038/cr.2008.174

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autologous peripheral blood stem cell tr

Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy

✍ Mohamed Mahdi-Rogers; Majid Kazmi; Rosalie Ferner; Richard A. C. Hughes; Susanne 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB

Autologous peripheral blood stem cell tr

Autologous peripheral blood stem cell transplantation for peripheral neuropathy secondary to monoclonal gammopathy of unknown significance

✍ Lee, Y C; Came, N; Schwarer, A; Day, B 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

Cytomegalovirus enteritis after autologo

Cytomegalovirus enteritis after autologous peripheral blood stem cell transplantation

✍ T. Kozuka; K. Takenaka; K. Shinagawa; K. Masuda; T. Ishihara; Y. Arimori; S. Fuk 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 37 KB

Cerebral Toxoplasmosis After Autologous

Cerebral Toxoplasmosis After Autologous Peripheral Blood Stem Cell Transplantation

✍ M. López-Duarte; A. Insunza; E. Conde; A. Iriondo; F. Mazorra; A. Zubizarreta 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 118 KB

Autoreactive antibodies following autolo

Autoreactive antibodies following autologous peripheral blood stem cell transplantation

✍ Ishikawa, F; Shigematsu, H; Gondo, H; Okamura, T; Niho, Y 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 31 KB

Autologous peripheral blood progenitor c

Autologous peripheral blood progenitor cell transplantation

✍ Kenneth C. Anderson 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 871 KB

Harvesting of autologous peripheral blood stem cells (PBSCs) has been facilitated by using currently available, efficient apheresis technology at the time of rebound from chemotherapy while patients are receiving recombinant growth factors, i.e., granulocyte (G) or granulocyte-macrophage (GM) colony